COVID-19 and Sunlight: Impact on SARS-CoV-2 Transmissibility, Morbidity, and Mortality
Overview
Authors
Affiliations
Coronavirus disease 2019 (COVID-19) has already affected millions of people worldwide. There are reports of SARS-CoV-2 transmission as a consequence of environmental contamination. The SARS-CoV-2 laden infective droplets can actively persist on the surface of different materials for several hours to days. Sunlight can affect the stability of SARS-CoV-2 in these aerosols and thereby have an impact on the decay rate of the virus. Solar radiation might play an important role in inactivating SARS-CoV-2 that persists in different surfaces and the environment. Among the different climatological factors, ultraviolet radiation was found to have an important role in determining the spread of SARS-CoV-2. Although ultraviolet radiation C (UVC), UVB, UVA, visible light, and infrared radiation possess germicidal properties, human CoVs including the recently emerged SARS-CoV-2 are inherently sensitive to UVC. However, the successful decontamination using other wavebands requires higher dosages and longer administration times. Furthermore, studies have also identified association between COVID-19 fatalities and the latitude. The intensity of sunlight is highest near the equator, and therefore populations in these regions with more regular exposure to sunlight are less susceptible to vitamin D deficiency. This article has analyzed the potential impact of sunlight in reducing SARS-CoV-2 transmissibility, morbidity, and mortality. It is evident that there exists an interesting link between sunlight exposure, latitude, and vitamin D status with COVID-19 incidence, fatality and recovery rates that requires further investigation.
Gong Z, Song T, Hu M, Che Q, Guo J, Zhang H BMC Public Health. 2024; 24(1):2196.
PMID: 39138466 PMC: 11321203. DOI: 10.1186/s12889-024-19749-3.
Winalai C, Anupong S, Modchang C, Chadsuthi S Heliyon. 2024; 10(9):e30319.
PMID: 38711630 PMC: 11070856. DOI: 10.1016/j.heliyon.2024.e30319.
Verani M, Pagani A, Federigi I, Lauretani G, Atomsa N, Rossi V Viruses. 2024; 16(3).
PMID: 38543847 PMC: 10975420. DOI: 10.3390/v16030482.
de Menezes-Junior L, de Moura S, Miranda A, Andrade A, Machado-Coelho G, Meireles A BMC Public Health. 2023; 23(1):1116.
PMID: 37308867 PMC: 10258778. DOI: 10.1186/s12889-023-16041-8.
Involvement of the secosteroid vitamin D in autoimmune rheumatic diseases and COVID-19.
Cutolo M, Smith V, Paolino S, Gotelli E Nat Rev Rheumatol. 2023; 19(5):265-287.
PMID: 36977791 PMC: 10043872. DOI: 10.1038/s41584-023-00944-2.